Cosyne Therapeutics Limited

DataGardener
cosyne therapeutics limited
live
Small

Cosyne Therapeutics Limited

13171951•Private Limited With Share Capital

2 Sheraton Street, Wework Medius House, London, W1F8BH

Get Full Access

Visit WebsiteBook a Direct Call
Incorporated

01/02/2021

Company Age

5 years

Directors

4

Employees

21

SIC Code

72110

Risk

low risk

Company Overview

Registration, classification & business activity

Cosyne Therapeutics Limited (13171951) is a private limited with share capital incorporated on 01/02/2021 (5 years old) and registered in london, W1F8BH. The company operates under SIC code 72110 - research and experimental development on biotechnology.

Cosyne therapeutics is a vertically integrated ai drug discovery company aiming to bring speed to precision medicine through polymathic ai to help patients with under-served diseases of the brain.

Private Limited With Share Capital
SIC: 72110
Small
Incorporated 01/02/2021
W1F8BH
21 employees

Financial Overview

Total Assets

£3.87M

Liabilities

£1.75M

Net Assets

£2.11M

Est. Turnover

£3.54M

AI Estimated
Unreported
Cash

£2.80M

Key Metrics

21

Employees

4

Directors

28

Shareholders

3

PSCs

Board of Directors

4
L
liisi laaniste
director
L
louwai muhammed
director
G
gillian margaret cannon
director
R
robert elliott
director

Filed Documents

39
Confirmation Statement With Updates
Category:Confirmation Statement
Date:03-03-2026
Replacement Filing Of Director Appointment With Name
Category:Officers
Date:03-03-2026
Change Person Director Company With Change Date
Category:Officers
Date:11-02-2026
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:20-06-2025
Appoint Person Director Company With Name Date
Category:Officers
Date:09-06-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:03-02-2025
Capital Name Of Class Of Shares
Category:Capital
Date:25-10-2024
Capital Allotment Shares
Category:Capital
Date:21-10-2024
Resolution
Category:Resolution
Date:19-10-2024
Memorandum Articles
Category:Incorporation
Date:19-10-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:09-10-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:24-05-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:15-02-2024
Resolution
Category:Resolution
Date:01-09-2023
Capital Allotment Shares
Category:Capital
Date:24-08-2023
Capital Name Of Class Of Shares
Category:Capital
Date:06-07-2023
Memorandum Articles
Category:Incorporation
Date:27-06-2023
Resolution
Category:Resolution
Date:27-06-2023
Termination Director Company With Name Termination Date
Category:Officers
Date:13-06-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:02-06-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:07-02-2023
Change Person Director Company With Change Date
Category:Officers
Date:07-02-2023
Notification Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:07-09-2022
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:07-09-2022
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:06-09-2022
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:06-09-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:22-08-2022
Capital Allotment Shares
Category:Capital
Date:04-08-2022
Memorandum Articles
Category:Incorporation
Date:07-06-2022
Resolution
Category:Resolution
Date:07-06-2022
Memorandum Articles
Category:Incorporation
Date:12-05-2022
Resolution
Category:Resolution
Date:12-05-2022
Memorandum Articles
Category:Incorporation
Date:12-05-2022
Resolution
Category:Resolution
Date:12-05-2022
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:18-03-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:08-02-2022
Capital Allotment Shares
Category:Capital
Date:27-09-2021
Capital Alter Shares Subdivision
Category:Capital
Date:27-09-2021
Incorporation Company
Category:Incorporation
Date:01-02-2021

Innovate Grants

1

This company received a grant of £349999.0 for Commercialising The Next Generation Of Synthetic Lethality: Preclinical Validation Of Lead Drug-Targets And Discovery Platform. The project started on 01/01/2022 and ended on 30/06/2023.

Import / Export

Imports
12 Months9
60 Months29
Exports
12 Months1
60 Months1

Risk Assessment

low risk

International Score

Future Factor

excellent

Performance Rating

Accounts

Typetotal exemption full
Due Date30/11/2026
Filing Date20/06/2025
Latest Accounts28/02/2025

Trading Addresses

2 Sheraton Street, Wework Medius House, London, W1F 8Bh, W1F8BHRegistered

Related Companies

2
16 courtfield gardens ltd
live
dr muhammed limited
live

Contact

2 Sheraton Street, Wework Medius House, London, W1F8BH